Barclays’s Dermira, Inc. DERM Stock Holding History

Barclays’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,000	Closed	-$607K	–	6712
2019 Q4	$607K	Buy	+40,000	New	+$345K	﹤0.01%	4123
2018 Q1	–	Sell	-11,400	Closed	-$317K	–	7503
2017 Q4	$317K	Buy	+11,400	New	+$302K	﹤0.01%	4287
2016 Q4	–	Sell	-92,500	Closed	-$3.13M	–	6967
2016 Q3	$3.13M	Hold	92,500	–	–	﹤0.01%	1637
2016 Q2	$2.71M	Buy	+92,500	New	+$2.55M	﹤0.01%	1764

Barclays's DERM Position: Q1 2020 in Review

Barclays sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 218,797 shares — an estimated $3.32M sold.

Barclays first reported a position in DERM in Q4 2014 and held it in 21 quarters. The position peaked at $3.42M in Q2 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Barclays reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Barclays sold 218,797 Dermira, Inc. shares in Q1 2020, an estimated $3.32M.
Barclays first reported a position in Dermira, Inc. in Q4 2014 and held it in 21 quarters.
Barclays's Dermira, Inc. position peaked at $3.42M in Q2 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.